Mostafa Kamal talks evolution of PBM industry, latest developments, in Fierce Healthcare panel

Industry experts share new insights from PBM industry, including GLP-1 weight-loss drugs, biosimilars and rising pharmaceutical costs

January 30, 2024

Prime Therapeutics CEO and President Mostafa Kamal recently joined industry experts in a panel discussion about the evolving landscape of pharmacy benefit managers (PBMs).

On Jan. 18, Kamal joined moderators from Fierce Healthcare and panelists Adam Kautzner (President, Express Scripts), John O’Brien (President and CEO, National Pharmaceutical Council), and Anthony Loiacono (CEO, Capital Rx) in a panel entitled “Pharmacy Benefit Managers: The Evolving Discussion.”

“If you reflect on the history of PBMs, this industry has had an amazing track record of redefining itself every half a decade to decade, essentially to meet the emerging and evolving needs,” Kamal says. “I can’t think of a more exciting time to be in this industry. I think the innovation we’re seeing around pharmaceutical products creates a lot of hope.”

Experts explored the issues, changes and challenges impacting the role and influence of PBMs, delving into hot topics such as GLP-1 weight-loss drugs, biosimilars, rising pharmaceutical costs and the future of the PBM industry.

“With the proliferation of technology—artificial intelligence and other tools that we see emerging around us—I think it’s a unique moment in time for us to be able to look at the macro trends, identify significant needs and bring in technology to help us solve and move forward in ways that go beyond what we’ve done historically,” Kamal says, “which is managing unit costs and managing utilization, and move PBMs more toward managing total experiences and affordability and outcomes for patients—total health outcomes.”

Register for free to see the full panel discussion, then click on “Sessions” then “Panel: Pharmacy Benefit Managers: The Evolving Discussion | Closing Remarks.”

Related news

Stories

February 2, 2024

Prime Therapeutics/Magellan Rx honors World Cancer Day, supports innovative oncology care

Prime is committed to closing gaps in cancer care by delivering meaningful oncology solutions to help people living with cancer.

Stories

January 24, 2024

Newsweek names Prime/MRx to its 2024 America’s Greatest Workplaces for Diversity list

Honor demonstrates Prime/MRx’s impact and commitment to delivering diverse and inclusive work environment

Stories

January 9, 2024

LISTEN NOW: Get the Skinny on GLP-1s — Pharmacy Friends podcast

In this episode, industry experts discuss clinical evidence, drug information and appropriate patient selection for GLP1 use.